Valsts: Austrālija
Valoda: angļu
Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)
Phentermine
PHENTERMINE RESIN - VALEANT _(PHENTERMINE) _PRODUCT INFORMATION NAME OF THE MEDICINE Phentermine (phenyl tertiary butylamine, C 10 H 15 N), Molecular weight: 149.233, CAS Registry No: 122-09-8 H CH 3 ⏐ ⏐ ⎯C⎯C NH 2 ⏐ ⏐ H CH 3 DESCRIPTION Each Phentermine Resin - Valeant capsule contains phentermine as an ion-exchange resin complex equivalent to 15, 30 or 40 mg phentermine depending on strength. The ion-exchange resin is quite stable, highly insoluble and without pharmacological effect until it reacts with cations (hydrogen, potassium, sodium etc) present in the gastrointestinal fluids. Phentermine is then released from the resin complex at a rate dependent on the total concentration of these cations. Since this concentration is fairly constant throughout the entire gastrointestinal tract, continuous and controlled ionic release occurs over a 10 to 14 hour period. Each Phentermine Resin - Valeant capsule also contains, as inactive ingredients, polystyrene sulfonate – sodium, lactose, liquid paraffin, magnesium stearate, gelatin, titanium dioxide and iron oxide black (CI 77499). In addition Phentermine Resin - Valeant 15 also contains brilliant blue FCF (CI 42090), iron oxide yellow (CI 77492); Phentermine Resin - Valeant 30 also contains iron oxide red (CI 77491); Phentermine Resin - Valeant 40 also contains erythrosine (CI 45430), sunset yellow FCF (CI 15985). Phentermine Resin - Valeant capsules are gluten-free_._ PHARMACOLOGY PHARMACODYNAMIC PROPERTIES Phentermine is a sympathomimetic amine with significant anorectic activity in animal models. Its appetite suppressant effect is generally cons Izlasiet visu dokumentu